Secondary Navigation Menu

Audience Switcher Modal

Country and Audience Choose Modal

Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.

Scientific Congress Publications

Supported by Bayer Pharmaceuticals

ISPOR 2026

Incidence and Costs of Secondary Stroke Events in Patients with Ischemic Stroke or Transient Ischemic Attack of Non-Cardioembolic Origin
Presenting Author::
Jean Lee, et al.
Date:
Tuesday, May 19
Poster Session
Session 3 (EE215)
Incidence and Mortality Rates of Secondary Ischemic Strokes Among Medicare Fee-For-Service Beneficiaries in the United States
Presenting Author:
Jinlin Song, et al.
Date:
Tuesday, May 19
Poster Session: ​
Session 4 (CO125)
Healthcare Resource Utilization and Costs of Secondary Strokes in Medicare Fee-For-Service Beneficiaries in the United States
Presenting Author:
Emily Durden, et al.
Date:
Wednesday, May 20
Poster Session: ​
Session 5 (EE424)
Development and validation of an algorithm to identify aspirin use from electronic health records and claims data
Presenting Author:
Valerie Haley, et al.
Date:
Tuesday, May 19
Poster Session: ​
RWD76